SerenaGroup® is a global health care company with the mission of developing the world’s leading wound care and research centers dedicated to advancing the science of wound healing. Our focus is on clinical performance. Our aim: develop Centers of Excellence.
Dr. Thomas E. Serena MD FACS FACHM MAPWCA, Founder and Medical Director of The SerenaGroup®, a family of wound, hyperbaric and research companies, is a Phi Beta Kappa graduate of The College of William and Mary and Penn State Medical School.
To date he has opened and operates wound care centers across the United States and globally. Dr. Serena has been the lead or Principal Investigator in over 100 clinical trials, including gene therapy for critical limb ischemia, antimicrobial dressings, growth factors, topical and parenteral antibiotics and CTP therapy. He holds numerous patents on wound care devices and dressings.
He is recognized internationally as an expert in the field of wound healing: he has more than 200 published papers and has given more than 1000 invited lectures throughout the world.
“I founded the SerenaGroup to develop Centers of Excellence in Wound Care. My vision was to establish clinics dedicated to the best possible patient care and committed to clinical research in the field. We have achieved this goal.”
– T. Serena
C = Clinical Excellence
O = Outreach
R = Research
E = Education
Clinical Documentation, Ongoing Monthly Reviews, Reimbursement, and Regulatory Oversight, Reviews
Comprehensive Care Model